Latham & Watkins has advised Natixis and BNP Paribas on the transaction. The transaction was structured as a 3-year revolving credit facility. The facility was sized in...
BlackRock’s $250 Million Revolving Financing
Sue Gove’s Dismissal of Putative Securities Class Action
Cleary Gottlieb represented Sue Gove, the CEO of Bed Bath & Beyond Inc., in successfully obtaining the dismissal of a putative securities class action in the...
407 International’s C$500 Million Medium-Term Notes Offering
Torys acted as counsel to 407 International in the offering. 407 International Inc. (“407 International”) announced that it agreed to issue C$500 million (approximately USD$ 375 million) aggregate...
BVP Forge’s Investment in Parsec Automation Corp
DLA Piper advised BVP Forge in the transaction. BVP Forge executed an investment in Parsec Automation Corp (Parsec), a Manufacturing Operations Management (MOM) software company. BVP...
Blackstone Strategic Credit 2027 Term Fund’s $45 Million Private Placement Offering
Simpson Thacher & Bartlett represented Blackstone Strategic Credit 2027 Term Fund in the deal. Blackstone Strategic Credit 2027 Term Fund (NYSE:BGB) announced a private placement of fixed-rate...
Vital Biosciences’ US$18 Million Series A Financing Round
Osler, Hoskin & Harcourt LLP advised Vital Bioscience on the transaction. Vital Biosciences announced that they raised around US$18 million in a Series A financing round...
Lone View Capital’s Strategic Investment in Smartlinx
Ropes & Gray represented Lone View Capital in the deal. Lone View Capital announced its majority stake acquisition of Smartlinx. The investment will help Smartlinx expand its...
Fifth Third Bancorp’s $1.25 Billion Senior Notes Offering
Bricker Graydon LLP advised Fifth Third Bancorp, while Davis Polk & Wardwell advised the underwriters in the offering. Fifth Third Bancorp announced an SEC-registered offering of $1.25...
Bain Capital’s $1.15 Billion Inaugural Insurance Fund Closing
Debevoise & Plimpton LLP advised Bain Capital on the deal. Bain Capital Insurance announced the final close of its inaugural private equity fund, Bain Capital Insurance Fund, L.P....
ImmunoGen’s Multi-Target License and Option Agreement with ImmunoBiochem
Ropes & Gray represented ImmunoGen in the deal. ImmunoGen, Inc. announced a multi-target license and option agreement to research novel, first-in-class ADCs with ImmunoBiochem Corporation on the...
Alexion, AstraZeneca Rare Disease in Deal with Pfizer
Covington & Burling advised Alexion on the transaction while Arnold & Porter represented Pfizer. AstraZeneca Rare Disease announced its entry into a definitive purchase and license agreement...
Kriya’s $150 Million Series C Extension
Cooley advised Kriya on the fundraising. Kriya Therapeutics, Inc. announced the addition of over $150 million in capital committed as part of its Series C Financing,...